Provided by Tiger Fintech (Singapore) Pte. Ltd.

Supernus Pharmaceuticals

32.34
-1.2500-3.72%
Volume:690.52K
Turnover:22.58M
Market Cap:1.81B
PE:29.22
High:33.83
Open:33.83
Low:32.20
Close:33.59
Loading ...

3 Small-Cap Stocks Skating on Thin Ice

StockStory
·
13 Mar

Supernus Pharmaceuticals, Inc. (SUPN): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts

Insider Monkey
·
07 Mar

Piper Sandler Reaffirms Their Hold Rating on Supernus Pharmaceuticals (SUPN)

TIPRANKS
·
06 Mar

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

StockStory
·
04 Mar

Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals?

Simply Wall St.
·
03 Mar

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
03 Mar

Supernus Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
27 Feb

Q4 2024 Supernus Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
27 Feb

Supernus Pharmaceuticals Price Target Maintained With a $36.00/Share by Cantor Fitzgerald

Dow Jones
·
26 Feb

Stifel Nicolaus Remains a Hold on Supernus Pharmaceuticals (SUPN)

TIPRANKS
·
26 Feb

Supernus Pharmaceuticals Q4 Earnings, Revenue Rise; Provides 2025 Revenue Guidance

MT Newswires Live
·
26 Feb

Supernus Pharmaceuticals Inc (SUPN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com
·
26 Feb

Supernus Pharmaceuticals Reports Strong 2024 Financial Growth

TIPRANKS
·
26 Feb

Supernus Pharmaceuticals: Strong Buy Rating Backed by Qelbree’s Growth and Promising Revenue Outlook

TIPRANKS
·
26 Feb

Supernus (SUPN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
26 Feb

Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates

Zacks
·
26 Feb

Supernus Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Supernus: Q4 Earnings Snapshot

Associated Press Finance
·
26 Feb

Supernus Pharmaceuticals Q4 EPS $0.27 Misses $0.52 Estimate, Sales $174.16M Beat $155.25M Estimate

Benzinga
·
26 Feb

BRIEF-Supernus Pharmaceuticals Q4 Product Sales USD 166.4 Million

Reuters
·
26 Feb